🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sarah Ferguson

The Ohio State University Wexner Medical Center

ORCID: 0000-0003-4003-5585

Also affiliated with The Ohio State University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer”.

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer

Investigational New Drugs(2025)10.1007/s10637-025-01591-y
N/A
0.165DataRank · unranked
2 citations

Ruohan Wu, Lai Wei, Mikhail M. Dikov, Shankar Suman, Po‐Lan Su +17 more

A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1552
N/A
0DataRank · unranked
36 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090
N/A
0DataRank · unranked
0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090.v1
N/A
0DataRank · unranked
0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more